Download PDF
CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2011; 21(02): 121-123
DOI: 10.4103/0971-3026.82296
Interventional Radiology

Technical note: Radiofrequency ablation of hepatocellular carcinoma with contrast-enhanced ultrasound guidance: First Indian experience

Atul Kapoor
Department of Interventional Radiology, Advanced Diagnostics and Institute of Imaging, Amritsar, Punjab, India
,
Aprajita Kapoor
Department of Interventional Radiology, Advanced Diagnostics and Institute of Imaging, Amritsar, Punjab, India
,
Goldaa Mahajan
Department of Interventional Radiology, Advanced Diagnostics and Institute of Imaging, Amritsar, Punjab, India
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
Also available at
  PDF Download Permissions and Reprints

Abstract

Radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) is an established alternative treatment to surgery and intra-arterial chemotherapy, usually performed under contrast-enhanced CT scan guidance. We describe our experience with the use of contrast-enhanced ultrasound and contrast dynamics analysis for planning and monitoring RFA in a patient with HCC.

Keywords

Contrast-enhanced ultrasound - hepatocellular carcinoma - radiofrequency ablation


Publication History

Article published online:
30 July 2021

© 2011. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
  • 2 Ng KK, Poon RT. Radiofrequency ablation for malignant liver tumor. Surg Oncol 2005;14:41-52.
  • 3 Wen YL, Kudo M, Zheng RQ, Minami Y, Chung H, Suetomi Y, et al. Radiofrequency ablation of hepatocellular carcinoma: Therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003;181:57-63.
  • 4 Cioni D, Lencioni R, Rossi S, Garbagnati F, Donati F, Crocetti L, et al. Radiofrequency thermal ablation of hepatocellular carcinoma: Using contrast-enhanced harmonic power Doppler sonography to assess treatment outcome. AJR Am J Roentgenol 2001;177:783-8.
  • 5 Chhabra DG, Shah RC, Parikh V, Jagannath P. Radiofrequency ablation of liver tumors: Experience with open and percutaneous approach. Indian J Gastroenterol 2006;25:66-70.
  • 6 Solbiati L, Ierace T, Tonolini M, Cova L. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 2004;51 Suppl:S19-23.
  • 7 Kim SK, Lim HK, Kim YH, Lee WJ, Lee SJ, Kim SH, et al. Hepatocellular carcinoma treated with radio-frequency ablation: Spectrum of imaging findings. Radiographics 2003;23:107-21.
  • 8 Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al. Hepatocellular carcinoma: Radio-frequency ablation of medium and large lesions. Radiology 2000;214:761-8.